Form D · Biotechnology
AKONNI BIOSYSTEMS INC
Fredrick, MD · CIK 0001254334
Offering snapshot reported Jun 19, 2019 · SEC filing
- Reported sold
- $1.78M Offering amount: $4.6M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jun 4, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 19, 2019 | Initial | $1,775,000 | No comparison | 21 | SEC filing |
| Aug 15, 2018 | Initial | $1,105,000 | No comparison | 16 | SEC filing |
| Feb 22, 2018 | Initial | $7,500,000 | No comparison | 1 | SEC filing |
| Jan 30, 2018 | Initial | $2,358,583 | No comparison | 26 | SEC filing |
| Sep 7, 2017 | Amendment | $2,346,182 | $0vs Sep 6, 2017 | 18 | SEC filing |
| Sep 6, 2017 | Initial | $2,346,182 | No comparison | 10 | SEC filing |
| Mar 16, 2017 | Initial | $4,000,000 | No comparison | 33 | SEC filing |
| May 20, 2016 | Amendment | $1,315,250 | $515,250vs May 13, 2016 | 4 | SEC filing |
| May 13, 2016 | Initial | $800,000 | No comparison | 4 | SEC filing |
| Dec 7, 2015 | Amendment | $618,998 | $250,002vs Apr 21, 2015 | 7 | SEC filing |
| Apr 21, 2015 | Initial | $368,996 | No comparison | 7 | SEC filing |
| May 14, 2012 | Amendment | $2,127,919 | $1,193,269vs Jan 17, 2012 | 3 | SEC filing |
| Jan 17, 2012 | Initial | $934,650 | No comparison | 3 | SEC filing |
| Dec 13, 2010 | Initial | $912,598 | No comparison | 9 | SEC filing |
| Mar 16, 2010 | Amendment | $5,000,000 | $3,833,614vs Apr 6, 2009 | 43 | SEC filing |
| May 14, 2009 | Amendment | $1,394,917 | No comparison | Not reported | SEC filing |
| Apr 6, 2009 | Initial | $1,166,386 | No comparison | Not reported | SEC filing |
| Feb 19, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 5, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 26, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 16, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 16, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-342273
Source: Form D, filed Jun 19, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Darrell Chandler | Executive |
| Charles Daitch | Director, Executive |
| Jon Davis | Executive |
| Michael Farmer | Director |
| Lawrence Firestone | Executive |
| Dr. Myun Han | Director |
| Thomas Higgins | Director |
| David Keys | Director |
| Tom Mc Mahon | Director |
| Brian Morra | Director |
| Michael Murphy | Executive |
| Chuck Parrish | Director |
| Ron Pion | Director, Executive |
| Mary Pitman | Director |
| Mary Pittman | Director |
| Jennifer Reynolds | Executive |
| George Rudy | Executive |
| Mark Wood | Director |
| Dr. Jialu Wu | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
400 Sagner Suite 300
Fredrick, MD, 21701
Fredrick, MD, 21701